| Year |
Citation |
Score |
| 2015 |
Magbanua MJ, Wolf DM, Yau C, Davis SE, Crothers J, Au A, Haqq CM, Livasy C, Rugo HS, Esserman L, Park JW, van 't Veer LJ. Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response. Breast Cancer Research : Bcr. 17: 73. PMID 26021444 DOI: 10.1186/s13058-015-0582-3 |
0.626 |
|
| 2015 |
Lang JE, Scott JH, Wolf DM, Novak P, Punj V, Magbanua MJ, Zhu W, Mineyev N, Haqq CM, Crothers JR, Esserman LJ, Tripathy D, van 't Veer L, Park JW. Expression profiling of circulating tumor cells in metastatic breast cancer. Breast Cancer Research and Treatment. 149: 121-31. PMID 25432738 DOI: 10.1007/s10549-014-3215-0 |
0.632 |
|
| 2014 |
Taplin ME, Montgomery B, Logothetis CJ, Bubley GJ, Richie JP, Dalkin BL, Sanda MG, Davis JW, Loda M, True LD, Troncoso P, Ye H, Lis RT, Marck BT, Matsumoto AM, ... ... Haqq CM, et al. Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3705-15. PMID 25311217 DOI: 10.1200/Jco.2013.53.4578 |
0.348 |
|
| 2014 |
Magbanua MJ, Richman EL, Sosa EV, Jones LW, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. Physical activity and prostate gene expression in men with low-risk prostate cancer. Cancer Causes & Control : Ccc. 25: 515-23. PMID 24504435 DOI: 10.1007/s10552-014-0354-x |
0.677 |
|
| 2013 |
Harland S, Staffurth J, Molina A, Hao Y, Gagnon DD, Sternberg CN, Cella D, Fizazi K, Logothetis CJ, Kheoh T, Haqq CM, de Bono JS, Scher HI. Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy. European Journal of Cancer (Oxford, England : 1990). 49: 3648-57. PMID 23973186 DOI: 10.1016/j.ejca.2013.07.144 |
0.375 |
|
| 2013 |
Ryan CJ, Molina A, Li J, Kheoh T, Small EJ, Haqq CM, Grant RP, de Bono JS, Scher HI. Serum androgens as prognostic biomarkers in castration-resistant prostate cancer: results from an analysis of a randomized phase III trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2791-8. PMID 23816964 DOI: 10.1200/JCO.2012.45.4595 |
0.373 |
|
| 2012 |
Logothetis CJ, Basch E, Molina A, Fizazi K, North SA, Chi KN, Jones RJ, Goodman OB, Mainwaring PN, Sternberg CN, Efstathiou E, Gagnon DD, Rothman M, Hao Y, Liu CS, ... ... Haqq CM, et al. Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial. The Lancet. Oncology. 13: 1210-7. PMID 23142059 DOI: 10.1016/S1470-2045(12)70473-4 |
0.372 |
|
| 2011 |
Magbanua MJ, Roy R, Sosa EV, Weinberg V, Federman S, Mattie MD, Hughes-Fulford M, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. Plos One. 6: e24004. PMID 21912659 DOI: 10.1371/journal.pone.0024004 |
0.687 |
|
| 2011 |
Ryan CJ, Shah S, Efstathiou E, Smith MR, Taplin ME, Bubley GJ, Logothetis CJ, Kheoh T, Kilian C, Haqq CM, Molina A, Small EJ. Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4854-61. PMID 21632851 DOI: 10.1158/1078-0432.CCR-11-0815 |
0.392 |
|
| 2011 |
de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB, Saad F, Staffurth JN, Mainwaring P, Harland S, Flaig TW, Hutson TE, ... ... Haqq CM, et al. Abiraterone and increased survival in metastatic prostate cancer. The New England Journal of Medicine. 364: 1995-2005. PMID 21612468 DOI: 10.1056/Nejmoa1014618 |
0.36 |
|
| 2011 |
Chan JM, Weinberg V, Magbanua MJ, Sosa E, Simko J, Shinohara K, Federman S, Mattie M, Hughes-Fulford M, Haqq C, Carroll PR. Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes & Control : Ccc. 22: 141-50. PMID 21103921 DOI: 10.1007/s10552-010-9684-5 |
0.683 |
|
| 2010 |
Danila DC, Morris MJ, de Bono JS, Ryan CJ, Denmeade SR, Smith MR, Taplin ME, Bubley GJ, Kheoh T, Haqq C, Molina A, Anand A, Koscuiszka M, Larson SM, Schwartz LH, et al. Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 1496-501. PMID 20159814 DOI: 10.1200/Jco.2009.25.9259 |
0.388 |
|
| 2009 |
Lang JE, Magbanua MJ, Scott JH, Makrigiorgos GM, Wang G, Federman S, Esserman LJ, Park JW, Haqq CM. A comparison of RNA amplification techniques at sub-nanogram input concentration. Bmc Genomics. 10: 326. PMID 19619282 DOI: 10.1186/1471-2164-10-326 |
0.588 |
|
| 2008 |
Ornish D, Magbanua MJ, Weidner G, Weinberg V, Kemp C, Green C, Mattie MD, Marlin R, Simko J, Shinohara K, Haqq CM, Carroll PR. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proceedings of the National Academy of Sciences of the United States of America. 105: 8369-74. PMID 18559852 DOI: 10.1073/pnas.0803080105 |
0.663 |
|
| 2007 |
Bolton EC, So AY, Chaivorapol C, Haqq CM, Li H, Yamamoto KR. Cell- and gene-specific regulation of primary target genes by the androgen receptor. Genes & Development. 21: 2005-17. PMID 17699749 DOI: 10.1101/Gad.1564207 |
0.369 |
|
| 2007 |
Ryan CJ, Haqq CM, Simko J, Nonaka DF, Chan JM, Weinberg V, Small EJ, Goldfine ID. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer. Urologic Oncology. 25: 134-40. PMID 17349528 DOI: 10.1016/j.urolonc.2006.07.019 |
0.353 |
|
| 2005 |
Li S, Crothers J, Haqq CM, Blackburn EH. Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA. The Journal of Biological Chemistry. 280: 23709-17. PMID 15831499 DOI: 10.1074/Jbc.M502782200 |
0.324 |
|
| 2004 |
Vivienne Watson JE, Doggett NA, Albertson DG, Andaya A, Chinnaiyan A, Van Dekken H, Ginzinger D, Haqq C, James K, Kamkar S, Kowbel D, Pinkel D, Schmitt L, Simko JP, Volik S, et al. Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer Oncogene. 23: 3487-3494. PMID 15007382 DOI: 10.1038/sj.onc.1207474 |
0.368 |
|
| 2003 |
Fox MS, Ares VX, Turek PJ, Haqq C, Reijo Pera RA. Feasibility of global gene expression analysis in testicular biopsies from infertile men. Molecular Reproduction and Development. 66: 403-21. PMID 14579417 DOI: 10.1002/mrd.10364 |
0.309 |
|
| Show low-probability matches. |